Reaction

Kyphosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,751 reports · 70 co-occurring drugs

As of the last recalculation, Kyphosis appears in 1,751 FAERS reports alongside 70 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 54.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Alendronate Sodium	369	54.8	55.0
Ciclesonide	57	51.4	51.6
Chlorhexidine Gluconate	24	31.6	31.7
Psyllium Husk	24	29.3	29.3
Nystatin Ointment	53	24.7	24.8
Nystatin Cream	53	24.7	24.8
Nystatin	53	23.7	23.8
Raloxifene Hydrochloride	26	21.5	21.5
Valproate Sodium	36	21.1	21.2
Temazepam	60	19.6	19.6
Ipratropium Bromide	56	19.2	19.3
Mepolizumab	69	17.1	17.2
Dorzolamide Hydrochloride And Timolol Maleate	11	16.6	16.7
Fluticasone Furoate And Vilanterol Trifenatate	47	15.9	16.0
Risedronate Sodium	38	14.8	14.8
Docusate Sodium - Sennosides	39	14.7	14.7
Cephalexin	24	13.4	13.4
Meperidine Hydrochloride	10	13.0	13.0
Polyethylene Glycol	11	12.1	12.2
Asfotase Alfa	10	11.9	11.9
Vitamin E	31	11.9	11.9
Clindamycin	28	11.9	11.9
Thalidomide	36	11.9	11.9
Clindamycin Phosphate	32	11.6	11.6
Carisoprodol	18	11.3	11.3
Phytonadione	8	11.3	11.3
Methocarbamol	21	11.1	11.1
Epoetin Alfa	11	11.1	11.1
Calcium	129	11.1	11.1
Melphalan Hydrochloride	23	11.0	11.0
Nitroglycerin	47	10.7	10.7
Exemestane	19	10.6	10.7
Melphalan	20	10.6	10.6
Dalteparin Sodium	9	10.2	10.2
Docusate Sodium	48	10.1	10.1
Amoxicillin And Clavulanate Potassium	22	9.7	9.7
Valsartan Oral	43	9.6	9.6
Theophylline	9	9.4	9.4
Amoxicillin	58	9.3	9.3
Chlorthalidone	9	9.3	9.3
Dronabinol	6	8.9	8.9
Teriparatide	80	8.8	8.8
Salmeterol Xinafoate	6	8.3	8.3
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin	14	8.1	8.2
Naproxen Sodium, Pseudoephedrine Hydrochloride	14	8.1	8.1
Oxycodone And Acetaminophen Tablets	8	8.0	8.0
Fulvestrant	22	8.0	8.0
Umeclidinium	6	8.0	8.0
Budesonide And Formoterol Fumarate Dihydrate	62	7.8	7.8
Cefepime	9	7.5	7.5
Zoledronic Acid	25	7.5	7.5
Lovastatin	16	7.5	7.5
Apixaban	41	7.4	7.4
Oxycodone Hydrochloride And Acetaminophen	57	7.1	7.1
Cefepime Hydrochloride	9	6.7	6.7
Eszopiclone	14	6.6	6.6
Estrogens, Conjugated	32	6.5	6.5
Bupivacaine	5	6.4	6.4
Conjugated Estrogens	30	6.2	6.2
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	5	5.9	5.9
Darbepoetin Alfa	25	5.6	5.6
Bortezomib	39	5.3	5.3
Fluticasone Propionate And Salmeterol	17	4.9	4.9
Denosumab	80	4.9	4.9
Conjugated Estrogens And Medroxyprogesterone Acetate	9	4.6	4.6
Loratadine And Pseudoephedrine Sulfate	3	4.5	4.5
Romosozumab-Aqqg	5	4.4	4.4
Hydrocodone Bitartrate	10	2.7	2.7
Cinacalcet Hydrochloride	9	2.3	2.3
Abaloparatide	5	2.0	2.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.